The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2015

Filed:

Oct. 04, 2006
Applicants:

Makoto Matsumoto, Tokushima, JP;

Hiroyuki Hashizume, Tokushima, JP;

Tatsuo Tomishige, Tokushima, JP;

Masanori Kawasaki, Tokushima, JP;

Yoshihiko Shimokawa, Tokushima, JP;

Inventors:

Makoto Matsumoto, Tokushima, JP;

Hiroyuki Hashizume, Tokushima, JP;

Tatsuo Tomishige, Tokushima, JP;

Masanori Kawasaki, Tokushima, JP;

Yoshihiko Shimokawa, Tokushima, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/454 (2006.01); A61K 31/496 (2006.01); A61K 31/4409 (2006.01); A61K 31/133 (2006.01); A61K 31/70 (2006.01); A61K 31/50 (2006.01); A61K 31/451 (2006.01); A61K 31/424 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/451 (2013.01); A61K 31/424 (2013.01); A61K 31/454 (2013.01); A61K 31/496 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention provides antituberculous therapeutic drugs with a higher potency. The present invention provides also antituberculous therapeutic drugs containing oxazole compounds represented by (I) general formula (1): [wherein Rrepresents a hydrogen atom or C1-6 alkyl group, n represents an integer of 0-6, and Rrepresents general formula (A) or the like, wherein Rrepresents a phenoxy group (at least one group selected from the group consisting of a halogen atom, an optionally halogen-substituted C1-6 alkyl group and an optionally halogen-substituted C1-6 alkoxy group may be substituted on the phenyl ring) or the like], optically active forms thereof or salts thereof, and drugs (II) such as primary antituberculous drugs.


Find Patent Forward Citations

Loading…